Loading…

Identification of the ataxin-1 interaction network and its impact on spinocerebellar ataxia type 1

Background Spinocerebellar ataxia type 1 (SCA1) is a neurodegenerative disease caused by a polyglutamine expansion in the ataxin-1 protein. The pathogenic mechanism resulting in SCA1 is still unclear. Protein–protein interactions affect the function and stability of ataxin-1. Methods Wild-type and m...

Full description

Saved in:
Bibliographic Details
Published in:Human genomics 2022-07, Vol.16 (1), p.1-29, Article 29
Main Authors: Chen, Jiu-Ming, Chen, Shi-Kai, Jin, Pei-Pei, Sun, Shun-Chang
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c574t-5fdd4a16fa594e11cd41b03477066e98604f09bb696cf9835e6668cc3dbb73f13
cites cdi_FETCH-LOGICAL-c574t-5fdd4a16fa594e11cd41b03477066e98604f09bb696cf9835e6668cc3dbb73f13
container_end_page 29
container_issue 1
container_start_page 1
container_title Human genomics
container_volume 16
creator Chen, Jiu-Ming
Chen, Shi-Kai
Jin, Pei-Pei
Sun, Shun-Chang
description Background Spinocerebellar ataxia type 1 (SCA1) is a neurodegenerative disease caused by a polyglutamine expansion in the ataxin-1 protein. The pathogenic mechanism resulting in SCA1 is still unclear. Protein–protein interactions affect the function and stability of ataxin-1. Methods Wild-type and mutant ataxin-1 were expressed in HEK-293T cells. The levels of expression were assessed using real-time polymerase chain reaction (PCR) and Western blots. Co-immunoprecipitation was done in HEK-293T cells expressing exogenous wild-type and mutant ataxin-1 using anti-Flag antibody following by tandem affinity purification in order to study protein–protein interactions. The candidate interacting proteins were validated by immunoprecipitation. Chromatin immunoprecipitation and high-throughput sequencing and RNA immunoprecipitation and high-throughput sequencing were performed using HEK-293T cells expressing wild-type or mutant ataxin-1. Results In this study using HEK-293T cells, we found that wild-type ataxin-1 interacted with MCM2, GNAS, and TMEM206, while mutant ataxin-1 lost its interaction with MCM2, GNAS, and TMEM206. Two ataxin-1 binding targets containing the core GGAG or AAAT were identified in HEK-293T cells using ChIP-seq. Gene Ontology analysis of the top ataxin-1 binding genes identified SLC6A15, NTF3, KCNC3, and DNAJC6 as functional genes in neurons in vitro. Ataxin-1 also was identified as an RNA-binding protein in HEK-293T cells using RIP-seq, but the polyglutamine expansion in the ataxin-1 had no direct effects on the RNA-binding activity of ataxin-1. Conclusions An expanded polyglutamine tract in ataxin-1 might interfere with protein–protein or protein–DNA interactions but had little effect on protein–RNA interactions. This study suggested that the dysfunction of protein–protein or protein–DNA interactions is involved in the pathogenesis of SCA1.
doi_str_mv 10.1186/s40246-022-00404-0
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4a33d990e13b442bbb59fbd304243165</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_4a33d990e13b442bbb59fbd304243165</doaj_id><sourcerecordid>2704101980</sourcerecordid><originalsourceid>FETCH-LOGICAL-c574t-5fdd4a16fa594e11cd41b03477066e98604f09bb696cf9835e6668cc3dbb73f13</originalsourceid><addsrcrecordid>eNpdkkuLFDEUhQtRnHH0D7gKuHFTevOopLIRZPDRMOBG1yHPmbTVSZmk1fn3ZroGcVwl5Jx83Hs4w_ASwxuMZ_62MiCMj0DICMCAjfBoOMdMyFFQzh7_cz8bntW6B6CYCvZ0OKOTBM4FOR_MzvnUYohWt5gTygG1G490079jGjGKqfmi7UlLvv3K5TvSyaHYKoqHtSuoK3WNKVtfvPHLosv2XaN2u3qEnw9Pgl6qf3F_XgzfPn74evl5vPryaXf5_mq0k2BtnIJzTGMe9CSZx9g6hg1QJkQf1cuZAwsgjeGS2yBnOnnO-WwtdcYIGjC9GHYb12W9V2uJB11uVdZRnR5yuVa6tGgXr5im1EkJHlPDGDHGTDIYR4ERRjGfOuvdxlqP5uCd7RkVvTyAPlRSvFHX-aeStGcrZAe8vgeU_OPoa1OHWO1dOsnnY1WkrzFPMyekW1_9Z93nY0k9KkUEMAxYztBdZHPZkmstPvwdBoO6q4Pa6qB6HdSpDgroH7R8ppY</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2704101980</pqid></control><display><type>article</type><title>Identification of the ataxin-1 interaction network and its impact on spinocerebellar ataxia type 1</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><creator>Chen, Jiu-Ming ; Chen, Shi-Kai ; Jin, Pei-Pei ; Sun, Shun-Chang</creator><creatorcontrib>Chen, Jiu-Ming ; Chen, Shi-Kai ; Jin, Pei-Pei ; Sun, Shun-Chang</creatorcontrib><description>Background Spinocerebellar ataxia type 1 (SCA1) is a neurodegenerative disease caused by a polyglutamine expansion in the ataxin-1 protein. The pathogenic mechanism resulting in SCA1 is still unclear. Protein–protein interactions affect the function and stability of ataxin-1. Methods Wild-type and mutant ataxin-1 were expressed in HEK-293T cells. The levels of expression were assessed using real-time polymerase chain reaction (PCR) and Western blots. Co-immunoprecipitation was done in HEK-293T cells expressing exogenous wild-type and mutant ataxin-1 using anti-Flag antibody following by tandem affinity purification in order to study protein–protein interactions. The candidate interacting proteins were validated by immunoprecipitation. Chromatin immunoprecipitation and high-throughput sequencing and RNA immunoprecipitation and high-throughput sequencing were performed using HEK-293T cells expressing wild-type or mutant ataxin-1. Results In this study using HEK-293T cells, we found that wild-type ataxin-1 interacted with MCM2, GNAS, and TMEM206, while mutant ataxin-1 lost its interaction with MCM2, GNAS, and TMEM206. Two ataxin-1 binding targets containing the core GGAG or AAAT were identified in HEK-293T cells using ChIP-seq. Gene Ontology analysis of the top ataxin-1 binding genes identified SLC6A15, NTF3, KCNC3, and DNAJC6 as functional genes in neurons in vitro. Ataxin-1 also was identified as an RNA-binding protein in HEK-293T cells using RIP-seq, but the polyglutamine expansion in the ataxin-1 had no direct effects on the RNA-binding activity of ataxin-1. Conclusions An expanded polyglutamine tract in ataxin-1 might interfere with protein–protein or protein–DNA interactions but had little effect on protein–RNA interactions. This study suggested that the dysfunction of protein–protein or protein–DNA interactions is involved in the pathogenesis of SCA1.</description><identifier>ISSN: 1479-7364</identifier><identifier>ISSN: 1473-9542</identifier><identifier>EISSN: 1479-7364</identifier><identifier>DOI: 10.1186/s40246-022-00404-0</identifier><identifier>PMID: 35906672</identifier><language>eng</language><publisher>London: BioMed Central</publisher><subject>Antibodies ; Ataxia ; Ataxin ; Ataxin-1 ; Chromatin ; Chromatography ; Cloning ; Deoxyribonucleic acid ; DNA ; Fluorides ; Gene expression ; Immunoprecipitation ; Mutants ; Mutation ; Neurodegenerative diseases ; Neurotoxicity ; Next-generation sequencing ; Pathway analysis ; Peptides ; Plasmids ; Polyglutamine diseases ; Polyglutamine expansion ; Polymerase chain reaction ; Protein interaction ; Protein purification ; Proteins ; Protein–protein interaction ; Ribonucleic acid ; RNA ; RNA-binding protein ; Spinocerebellar ataxia ; Spinocerebellar ataxia type 1 (SCA1) ; Trinucleotide repeat diseases ; Western blotting</subject><ispartof>Human genomics, 2022-07, Vol.16 (1), p.1-29, Article 29</ispartof><rights>2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c574t-5fdd4a16fa594e11cd41b03477066e98604f09bb696cf9835e6668cc3dbb73f13</citedby><cites>FETCH-LOGICAL-c574t-5fdd4a16fa594e11cd41b03477066e98604f09bb696cf9835e6668cc3dbb73f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2704101980/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2704101980?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,44569,53769,53771,74872</link.rule.ids></links><search><creatorcontrib>Chen, Jiu-Ming</creatorcontrib><creatorcontrib>Chen, Shi-Kai</creatorcontrib><creatorcontrib>Jin, Pei-Pei</creatorcontrib><creatorcontrib>Sun, Shun-Chang</creatorcontrib><title>Identification of the ataxin-1 interaction network and its impact on spinocerebellar ataxia type 1</title><title>Human genomics</title><description>Background Spinocerebellar ataxia type 1 (SCA1) is a neurodegenerative disease caused by a polyglutamine expansion in the ataxin-1 protein. The pathogenic mechanism resulting in SCA1 is still unclear. Protein–protein interactions affect the function and stability of ataxin-1. Methods Wild-type and mutant ataxin-1 were expressed in HEK-293T cells. The levels of expression were assessed using real-time polymerase chain reaction (PCR) and Western blots. Co-immunoprecipitation was done in HEK-293T cells expressing exogenous wild-type and mutant ataxin-1 using anti-Flag antibody following by tandem affinity purification in order to study protein–protein interactions. The candidate interacting proteins were validated by immunoprecipitation. Chromatin immunoprecipitation and high-throughput sequencing and RNA immunoprecipitation and high-throughput sequencing were performed using HEK-293T cells expressing wild-type or mutant ataxin-1. Results In this study using HEK-293T cells, we found that wild-type ataxin-1 interacted with MCM2, GNAS, and TMEM206, while mutant ataxin-1 lost its interaction with MCM2, GNAS, and TMEM206. Two ataxin-1 binding targets containing the core GGAG or AAAT were identified in HEK-293T cells using ChIP-seq. Gene Ontology analysis of the top ataxin-1 binding genes identified SLC6A15, NTF3, KCNC3, and DNAJC6 as functional genes in neurons in vitro. Ataxin-1 also was identified as an RNA-binding protein in HEK-293T cells using RIP-seq, but the polyglutamine expansion in the ataxin-1 had no direct effects on the RNA-binding activity of ataxin-1. Conclusions An expanded polyglutamine tract in ataxin-1 might interfere with protein–protein or protein–DNA interactions but had little effect on protein–RNA interactions. This study suggested that the dysfunction of protein–protein or protein–DNA interactions is involved in the pathogenesis of SCA1.</description><subject>Antibodies</subject><subject>Ataxia</subject><subject>Ataxin</subject><subject>Ataxin-1</subject><subject>Chromatin</subject><subject>Chromatography</subject><subject>Cloning</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Fluorides</subject><subject>Gene expression</subject><subject>Immunoprecipitation</subject><subject>Mutants</subject><subject>Mutation</subject><subject>Neurodegenerative diseases</subject><subject>Neurotoxicity</subject><subject>Next-generation sequencing</subject><subject>Pathway analysis</subject><subject>Peptides</subject><subject>Plasmids</subject><subject>Polyglutamine diseases</subject><subject>Polyglutamine expansion</subject><subject>Polymerase chain reaction</subject><subject>Protein interaction</subject><subject>Protein purification</subject><subject>Proteins</subject><subject>Protein–protein interaction</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>RNA-binding protein</subject><subject>Spinocerebellar ataxia</subject><subject>Spinocerebellar ataxia type 1 (SCA1)</subject><subject>Trinucleotide repeat diseases</subject><subject>Western blotting</subject><issn>1479-7364</issn><issn>1473-9542</issn><issn>1479-7364</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkkuLFDEUhQtRnHH0D7gKuHFTevOopLIRZPDRMOBG1yHPmbTVSZmk1fn3ZroGcVwl5Jx83Hs4w_ASwxuMZ_62MiCMj0DICMCAjfBoOMdMyFFQzh7_cz8bntW6B6CYCvZ0OKOTBM4FOR_MzvnUYohWt5gTygG1G490079jGjGKqfmi7UlLvv3K5TvSyaHYKoqHtSuoK3WNKVtfvPHLosv2XaN2u3qEnw9Pgl6qf3F_XgzfPn74evl5vPryaXf5_mq0k2BtnIJzTGMe9CSZx9g6hg1QJkQf1cuZAwsgjeGS2yBnOnnO-WwtdcYIGjC9GHYb12W9V2uJB11uVdZRnR5yuVa6tGgXr5im1EkJHlPDGDHGTDIYR4ERRjGfOuvdxlqP5uCd7RkVvTyAPlRSvFHX-aeStGcrZAe8vgeU_OPoa1OHWO1dOsnnY1WkrzFPMyekW1_9Z93nY0k9KkUEMAxYztBdZHPZkmstPvwdBoO6q4Pa6qB6HdSpDgroH7R8ppY</recordid><startdate>20220729</startdate><enddate>20220729</enddate><creator>Chen, Jiu-Ming</creator><creator>Chen, Shi-Kai</creator><creator>Jin, Pei-Pei</creator><creator>Sun, Shun-Chang</creator><general>BioMed Central</general><general>BMC</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220729</creationdate><title>Identification of the ataxin-1 interaction network and its impact on spinocerebellar ataxia type 1</title><author>Chen, Jiu-Ming ; Chen, Shi-Kai ; Jin, Pei-Pei ; Sun, Shun-Chang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c574t-5fdd4a16fa594e11cd41b03477066e98604f09bb696cf9835e6668cc3dbb73f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibodies</topic><topic>Ataxia</topic><topic>Ataxin</topic><topic>Ataxin-1</topic><topic>Chromatin</topic><topic>Chromatography</topic><topic>Cloning</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Fluorides</topic><topic>Gene expression</topic><topic>Immunoprecipitation</topic><topic>Mutants</topic><topic>Mutation</topic><topic>Neurodegenerative diseases</topic><topic>Neurotoxicity</topic><topic>Next-generation sequencing</topic><topic>Pathway analysis</topic><topic>Peptides</topic><topic>Plasmids</topic><topic>Polyglutamine diseases</topic><topic>Polyglutamine expansion</topic><topic>Polymerase chain reaction</topic><topic>Protein interaction</topic><topic>Protein purification</topic><topic>Proteins</topic><topic>Protein–protein interaction</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>RNA-binding protein</topic><topic>Spinocerebellar ataxia</topic><topic>Spinocerebellar ataxia type 1 (SCA1)</topic><topic>Trinucleotide repeat diseases</topic><topic>Western blotting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Jiu-Ming</creatorcontrib><creatorcontrib>Chen, Shi-Kai</creatorcontrib><creatorcontrib>Jin, Pei-Pei</creatorcontrib><creatorcontrib>Sun, Shun-Chang</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Databases</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Human genomics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Jiu-Ming</au><au>Chen, Shi-Kai</au><au>Jin, Pei-Pei</au><au>Sun, Shun-Chang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of the ataxin-1 interaction network and its impact on spinocerebellar ataxia type 1</atitle><jtitle>Human genomics</jtitle><date>2022-07-29</date><risdate>2022</risdate><volume>16</volume><issue>1</issue><spage>1</spage><epage>29</epage><pages>1-29</pages><artnum>29</artnum><issn>1479-7364</issn><issn>1473-9542</issn><eissn>1479-7364</eissn><abstract>Background Spinocerebellar ataxia type 1 (SCA1) is a neurodegenerative disease caused by a polyglutamine expansion in the ataxin-1 protein. The pathogenic mechanism resulting in SCA1 is still unclear. Protein–protein interactions affect the function and stability of ataxin-1. Methods Wild-type and mutant ataxin-1 were expressed in HEK-293T cells. The levels of expression were assessed using real-time polymerase chain reaction (PCR) and Western blots. Co-immunoprecipitation was done in HEK-293T cells expressing exogenous wild-type and mutant ataxin-1 using anti-Flag antibody following by tandem affinity purification in order to study protein–protein interactions. The candidate interacting proteins were validated by immunoprecipitation. Chromatin immunoprecipitation and high-throughput sequencing and RNA immunoprecipitation and high-throughput sequencing were performed using HEK-293T cells expressing wild-type or mutant ataxin-1. Results In this study using HEK-293T cells, we found that wild-type ataxin-1 interacted with MCM2, GNAS, and TMEM206, while mutant ataxin-1 lost its interaction with MCM2, GNAS, and TMEM206. Two ataxin-1 binding targets containing the core GGAG or AAAT were identified in HEK-293T cells using ChIP-seq. Gene Ontology analysis of the top ataxin-1 binding genes identified SLC6A15, NTF3, KCNC3, and DNAJC6 as functional genes in neurons in vitro. Ataxin-1 also was identified as an RNA-binding protein in HEK-293T cells using RIP-seq, but the polyglutamine expansion in the ataxin-1 had no direct effects on the RNA-binding activity of ataxin-1. Conclusions An expanded polyglutamine tract in ataxin-1 might interfere with protein–protein or protein–DNA interactions but had little effect on protein–RNA interactions. This study suggested that the dysfunction of protein–protein or protein–DNA interactions is involved in the pathogenesis of SCA1.</abstract><cop>London</cop><pub>BioMed Central</pub><pmid>35906672</pmid><doi>10.1186/s40246-022-00404-0</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1479-7364
ispartof Human genomics, 2022-07, Vol.16 (1), p.1-29, Article 29
issn 1479-7364
1473-9542
1479-7364
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_4a33d990e13b442bbb59fbd304243165
source PubMed (Medline); Publicly Available Content Database
subjects Antibodies
Ataxia
Ataxin
Ataxin-1
Chromatin
Chromatography
Cloning
Deoxyribonucleic acid
DNA
Fluorides
Gene expression
Immunoprecipitation
Mutants
Mutation
Neurodegenerative diseases
Neurotoxicity
Next-generation sequencing
Pathway analysis
Peptides
Plasmids
Polyglutamine diseases
Polyglutamine expansion
Polymerase chain reaction
Protein interaction
Protein purification
Proteins
Protein–protein interaction
Ribonucleic acid
RNA
RNA-binding protein
Spinocerebellar ataxia
Spinocerebellar ataxia type 1 (SCA1)
Trinucleotide repeat diseases
Western blotting
title Identification of the ataxin-1 interaction network and its impact on spinocerebellar ataxia type 1
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T19%3A25%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20the%20ataxin-1%20interaction%20network%20and%20its%20impact%20on%20spinocerebellar%20ataxia%20type%201&rft.jtitle=Human%20genomics&rft.au=Chen,%20Jiu-Ming&rft.date=2022-07-29&rft.volume=16&rft.issue=1&rft.spage=1&rft.epage=29&rft.pages=1-29&rft.artnum=29&rft.issn=1479-7364&rft.eissn=1479-7364&rft_id=info:doi/10.1186/s40246-022-00404-0&rft_dat=%3Cproquest_doaj_%3E2704101980%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c574t-5fdd4a16fa594e11cd41b03477066e98604f09bb696cf9835e6668cc3dbb73f13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2704101980&rft_id=info:pmid/35906672&rfr_iscdi=true